Covid fears drive Motor Expo sales

Published by
The Bangkok Post

Bookings at the Thailand International Motor Expo are expected to hit organisers’ target of 30,000 cars as Covid-19 safety concerns lead people to buy more vehicles, according to the Federation of Thai Industries (FTI). Though the pandemic meant organisers imposed strict screening of visitors, the 12-day event that ends tomorrow has received a positive response from consumers, said Surapong Paisitpatanapong, FTI vice-chairman and spokesman for the federation’s automotive club. In addition to sales promotions and new models pushing up car bookings, many people want to have their own vehicles to… Continue reading Covid fears drive Motor Expo sales

Junshi Biosciences Announces NMPA Accepted supplemental New Drug Application for Toripalimab in Combination with Chemotherapy as First-Line Treatment of Advanced NSCLC

6th indication for toripalimab submitted in China

SHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has accepted the company’s supplemental New Drug Application (“sNDA”) for toripalimab in combination with chemotherapy as the first-line treatment of patients with treatment-naive advanced or metastatic non-small cell lung cancer (“NSCLC”) with no EGFR or ALK tumor aberrations.

The sNDA is based on the CHOICE-01 study (NCT03856411), which is the first domestic randomized, double-blind, placebo parallel-controlled, multi-center, Phase III study of an anti-PD-1 monoclonal antibody in combination with chemotherapy as first-line treatment that recruits both histological types of advanced squamous and non-squamous NSCLC. Professor Jie Wang from Cancer Hospital, Chinese Academy of Medical Sciences is the leading principal investigator for the study. The study enrolled 465 NSCLC patients in 63 centers in China, among which 220 were squamous NSCLC patients and 245 were non-squamous NSCLC patients. Based on the interim analysis results of the CHOICE-01 study, the Independent Data Monitoring Committee (IDMC) determined that the primary endpoint of progression-free survival (“PFS”) has crossed the pre-defined efficacy boundary. The result of the study was presented during the Oral Session (abstract number MA13.08) at the 2021 World Conference on Lung Cancer (WCLC), showing that compared with chemotherapy alone, toripalimab in combination with chemotherapy as the first-line treatment for advanced NSCLC significantly prolonged the PFS of patients, reduced the risk of disease progression, and showed a positive trend in terms of overall survival (“OS”).

Junshi will submit further analysis of the results of OS of the CHOICE-01 study to the NMPA subsequently on a rolling basis and communicate with the US Food and Drug Administration (the “FDA”) on the same matter.

Lung cancer is currently the second most prevalent malignant tumor with the highest mortality rate in the world, and the most prevalent with the highest mortality rate in China. According to data released by the World Health Organization, in 2020, the number of new lung cancer cases in China was estimated to be 816,000 and accounted for 17.9% of all new cancer cases in China. In the same year, the number of lung cancer deaths in China amounted to 715,000 and accounted for 23.8% of all cancer deaths. NSCLC is a major subtype of lung cancer, accounting for approximately 85% of all cases. Existing domestic and overseas studies have shown that monotherapy or combination chemotherapy of anti-PD-(L)1 monoclonal antibody has already become new standard for the first-line treatment of NSCLC.

About Toripalimab
Toripalimab is an anti-PD-1 monoclonal antibody developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, and for enhanced receptor internalization (endocytosis function). Blocking PD-1 interactions with PD-L1 and PD-L2 is thought to recharge the immune system’s ability to attack and kill tumor cells. More than thirty company-sponsored toripalimab clinical studies covering more than fifteen indications have been conducted globally, including in China, the United States, Southeast Asia, and European countries. Ongoing or completed pivotal clinical trials evaluating the safety and efficacy of toripalimab cover a broad range of tumor types including cancers of the lung, nasopharynx, esophagus, stomach, bladder, breast, liver, kidney and skin.

In China, toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing (approved in China as TUOYI®). On December 17, 2018, toripalimab was granted a conditional approval by the National Medical Products Administration (NMPA) for the second-line treatment of unresectable or metastatic melanoma. In February 2021, the NMPA granted a conditional approval to toripalimab for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma (“NPC”) after failure of at least two lines of prior systemic therapy. In April, the NMPA granted a conditional approval to toripalimab for the treatment of patients with locally advanced or metastatic urothelial carcinoma who failed platinum-containing chemotherapy or progressed within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. In November 2021, the NMPA approved toripalimab in combination with cisplatin and gemcitabine as the first-line treatment for patients with locally recurrent or metastatic nasopharyngeal carcinoma. In addition, the supplemental NDA for the first-line treatment of patients with advanced or metastatic esophageal squamous cell carcinoma was accepted by the NMPA for review in July 2021.

In December 2020, toripalimab was successfully included in the updated National Reimbursement Drug List for the indication of the second-line treatment of unresectable or metastatic melanoma. In December 2021, two additional indications were included on the list: recurrent or metastatic nasopharyngeal carcinoma after failure of at least two lines of prior systemic therapy and locally advanced or metastatic urothelial carcinoma after failure of platinum-containing chemotherapy or progressed within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

In the United States, the FDA has granted priority review for the toripalimab BLA for the treatment of recurrent or metastatic NPC, an aggressive head and neck tumor which currently has no FDA-approved immuno-oncology treatment options. Earlier, the FDA granted Breakthrough Therapy designation for toripalimab in combination with chemotherapy for the 1st line treatment of recurrent or metastatic NPC as well as for toripalimab monotherapy in the second or third-line treatment of recurrent or metastatic NPC. Additionally, the FDA has granted Fast Track designation for toripalimab for the treatment of mucosal melanoma and orphan drug designation for esophageal cancer, NPC, mucosal melanoma and soft tissue sarcoma. Earlier in 2021, Coherus in-licensed rights to develop and commercialize toripalimab in the United States and Canada. Coherus and Junshi Biosciences plan to file additional toripalimab BLAs with the FDA over the next three years for multiple other cancer types.

About Junshi Biosciences
Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapeutics. The company has established a diversified R & D pipeline comprising 45 drug candidates, with five therapeutic focus areas covering cancer, autoimmune, metabolic, neurological, and infectious diseases. Junshi Biosciences was the first Chinese pharmaceutical company that obtained marketing approval for anti-PD-1 monoclonal antibody in China. Its first-in-human anti-BTLA antibody for solid tumors was the first in the world to be approved for clinical trials by the FDA and NMPA and its anti-PCSK9 monoclonal antibody was the first in China to be approved for clinical trials by the NMPA. In early 2020, Junshi Biosciences joined forces with the Institute of Microbiology of Chinese Academy of Science and Eli Lilly to co-develop JS016 (etesevimab), China’s first neutralizing fully human monoclonal antibody against SARS-CoV-2. JS016 administered with bamlanivimab has been granted Emergency Use Authorizations (EUA) in more than 15 countries and regions worldwide. The JS016 program is a part of our continuous innovation for disease control and prevention of the global pandemic. Junshi Biosciences has over 2,500 employees in the United States (San Francisco and Maryland) and China (Shanghai, Suzhou, Beijing and Guangzhou). For more information, please visit:

Junshi Biosciences Contact Information
IR Team:
Junshi Biosciences
+ 86 021-2250 0300

Solebury Trout
Bob Ai
+ 1 646-389-6658

PR Team:
Junshi Biosciences
Zhi Li
+ 86 021-6105 8800

Gloriae Dei Cantores’ Musical Advent Calendar is Available for Listening Now Through Christmas Day

World-renowned Gloriae Dei Cantores shares the gift of music every day of Advent to countdown to Christmas with the kids, friends and family.

Enjoy our Musical Advent Calendar

Enjoy our Musical Advent Calendar

ORLEANS, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) —  Gloriae Dei Cantores’ Musical Advent Calendar shares the gift of music every day of Advent.

Click here to receive the Musical Calendar via email and experience glorious music every day of Advent, or visit to follow their Musical Advent Calendar.

Looking for more ways to celebrate Christmas? Find peace, recollection and beauty listening to the Keeping Christmas recording by Gloriae Dei Cantores and enjoy a traditional “Service of Readings and Carols” at home. Intertwined with the tranquil and beautiful choral music of Gloriae Dei Cantores are readings reverently retelling the story of Christ’s birth. Sing along to beloved carols and anthems such as O Come All Ye Faithful, Silent Night, Angels we have heard on High, The First Nowell and more. Listen to the Missa ad Praesepe or Mass of the Cradle,  originally written for Westminster Cathedral in London. The recording runs about 70 minutes.

Order at and include a complimentary Christmas card when sending as a gift to a friend or loved one. Worldwide shipping available.

Listen or download digitally here to listen throughout Advent or on Christmas Eve.

Experience glorious music filled with peace and beauty this Christmas season.

Media Contact:

Gloriae Dei Cantores Recordings (

Related Images

Image 1: Enjoy our Musical Advent Calendar

Gloriae Dei Cantores Sings Christmas Carols!

This content was issued through the press release distribution service at

Attachment Aims to Build China’s First Carbon-neutral Logistics Industrial Park in Xi’an

JD employees working on the rooftop of a JD warehouse pioneered a rooftop distributed solar PV system in its Shanghai Asia No.1 in 2017, which now generates 3.11 million kWh per year, supplying the energy for warehouse lighting, automatic sorting, packaging, picking and other activities. Currently, JD has already finished installing PV systems at 12 logistics parks.

BEIJING, Dec. 10, 2021 (GLOBE NEWSWIRE) — is making progress in its construction of the first carbon-neutral intelligent industrial park for China’s logistics industry, with the Xi’an Asia No.1 logistics park expected to be carbon-neutral on the operations level by early 2022.

At nearly 300,000 square meters, JD’s Asia No.1 logistics park in Xi’an has deployed 100,000 square meters of rooftop solar PV with a capacity of 9 MW, which generated a total amount of about 8,500 MWh of electricity from January to October in 2021 — equivalent to providing electricity for about 3,900 Chinese households for a year, and reducing carbon emissions by approximately 5,670 tons when compared to purchasing electricity from local power plants.

JD’s new energy vehicle

Green transportation: 12,000 new energy vehicles reducing 120,000 tons of CO2 emissions per year. Over the past four years, JD has placed nearly 12,000 new energy vehicles in more than 50 cities across China and introduced more than 1,600 charging terminals, which can reduce up to 12,000 tons of CO2 emissions each year. JD Logistics is also the first logistics company in China to introduce the use of hydrogen-energy vehicles, which have been put into use in Shanghai, Guangzhou, and Foshan. In addition, by optimizing the warehousing network and transportation routes, JD can reduce the number of vehicles in transit, improve the full-load rate of round-trip vehicles and reduce vehicle waiting time.

In addition, Xi’an Asia No.1 can meet heating needs through distributed air conditioning instead of a conventional boiler room in certain areas. New energy is widely used in forklifts and other special equipment, including 22 sets of charging terminals that can support charging 44 vehicles at a time. Streetlights in the park will also gradually be replaced by solar lights. With the support of advanced technologies including 5G, blockchain and AI, JD is also researching an industry solution for carbon neutral parks by further improving operating efficiency and lowering energy consumption.

Green warehousing: Automation enabling warehouses to operate without lighting pioneered a rooftop-distributed solar PV system in its Shanghai Asia No.1 location in 2017, which now generates 3.11 million kWh per year, supplying the energy for warehouse lighting, automatic sorting, packaging, picking and other activities. Currently, JD has completed installation of PV systems at 12 logistics parks, while automation systems and robots also enable warehouses to operate without lighting. Such “dark operations” help save an average of 2,283 kWh per minute at JD’s logistics parks, which is equivalent to the electric consumption of a normal household for one and a half years.

According to forecasts, the total production capacity of JD’s PV system will reach 100 MW by the end of 2021, which could provide energy for 50,000 households in a year. And in three years, the capacity is estimated to reach 1,000 MW — contributing green energy to 85% of JD’s intelligent industrial parks.

Green packaging: Saving 400 million meters of tape a year

In 2015, proposed the concept of “Slim Tape,” which cut the width of packing tape from 53 mm to 45 mm and helped reduce 400 million meters of tape in 2020 – an amount that can circle the equator 10 times. Now, “Slim Tape” has been made standard for China’s postal industry and used in external logistics enterprises.

As early as 2015, also began to use reusable cold chain boxes for fresh produce business, making it the first e-commerce company in China to adopt reusable packaging. As a result: 180 million disposable foam boxes were saved from waste from 2015 to 2020. The reusable Green Stream Box, which can be used 50 times, was later introduced and has been widely used in over 30 cities in China.

JD also initiated China’s E-commerce & Logistics Packaging Standards Alliance and worked with brands to redesign e-commerce goods’ original packaging to prevent transportation damage and reduce the need for repackaging. As of now, brands including P&G, Unilever and others have reduced their use of logistics cartons and paper by 150 million pieces and 125,000 tons, respectively.

Green transportation: 12,000 new energy vehicles reducing 120,000 tons of CO2 emissions per year

Over the past four years, JD has placed nearly 12,000 new energy vehicles in more than 50 cities across China and introduced more than 1,600 charging terminals, which can reduce up to 120,000 tons of CO2 emissions each year. JD Logistics is also the first logistics company in China to introduce a fleet of hydrogen-energy vehicles, which have been put into use in Shanghai, Guangzhou and Foshan. In addition, by optimizing the warehousing network and transportation routes, JD can reduce the number of vehicles in transit, improve the full-load rate of round-trip vehicles and reduce vehicle waiting time. strives to build a green and low carbon business model and is leveraging its core competencies to continuously decrease its carbon footprint and operate a cleaner supply chain system.

About is a leading supply chain-based technology and service provider. The company’s cutting-edge retail infrastructure seeks to enable consumers to buy whatever they want, whenever and wherever they want it. The company has opened its technology and infrastructure to partners, brands and other sectors, as part of its Retail as a Service offering to help drive productivity and innovation across a range of industries.

Media Relations
+86 (10) 8911-6155

Photos accompanying this announcement are available at

The photos are also available at Newscom,, and via AP PhotoExpress.

Spend Matters Secures Investment From Copley Equity Partners

Proceeds to Fund Continued Growth in Procurement While Expanding into Adjacent Markets

BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Copley Equity Partners, LLC (“Copley”), a private investment firm focused on lower middle-market companies with strong growth opportunities, today announced that it has made an investment in Spend Matters, a proprietary tech-enabled data platform that drives and optimizes the strategic technology procurement decisions across the global procurement, finance, and supply chain technology ecosystem.

Spend Matters Founder and CEO Jason Busch will continue to lead the firm and remains a substantial equity holder. All Spend Matters analysts and employees will remain with the firm, which is based in Chicago, IL.

Proceeds from the investment will optimize and expand Spend Matters’ offerings for private and public sector organizations, consultants, private equity, and services/solution providers.

“Copley Equity Partners’ investment in Spend Matters sets the stage for our next phase of growth by allowing us to scale within procurement while expanding into adjacent technology markets,” said Spend Matters Founder and CEO, Jason Busch. “Copley’s resources and expertise will allow us to market and deploy our proprietary data platform into an array of technology markets, including accounts payable, B2B payments, supply chain analytics, ESG, and CSR.”

Spend Matters brings a unique data-driven approach to analyzing technology and solutions. The firm pioneered SolutionMap, a technology benchmarking methodology based equally on granular analyst technology assessments and customer reference inputs. In 2021, they launched TechMatch, the only SaaS application in the market that maps business requirements to technology vendor capability to drive accurate, data-based technology decision-making. TechMatch is used by Fortune 500 and Global 2000 firms, public sector organizations, and global consultancies to drive technology decision-making for procurement, accounts payable, contract management, and third-party management.

“Procurement technology has rapidly become a dominant area of SaaS investment for organizations of all sizes. Supply chain challenges, commodity inflation, and price volatility continue to elevate procurement into the boardroom and headlines,” says Peter Trovato, Co-Founder and Managing Director, Copley Equity Partners. “Spend Matters’ market leadership and high growth combined with its unique data-driven, tech-enabled approach to analyzing technology are disrupting the existing analyst and market intelligence ecosystem. We are thrilled to partner with management to infuse capital and strategic knowledge to accelerate the growth of the business.”

“No competitor has the amount of actionable data and intelligence that Spend Matters has in this space across such a sphere of influence,” says Eleanor Bennett, Senior Associate, Copley Equity Partners. “Copley was especially impressed by Spend Matters’ ability to influence purchasing decisions at multiple levels in multiple markets, from day-to-day procurement all the way through an enterprise’s digital transformation. Whether it’s for sales and marketing, or product teams building best of breed solutions and go-to-market strategies, consulting firms that need fast answers to client questions, or for private equity firms in need of data-driven due diligence and benchmarking, Spend Matters can meet that need through a unique asset with global scalability.”

Spend Matters was advised by JEGI CLARITY (exclusive financial advisor) and Neal, Gerber & Eisenberg LLP (legal advisor). Copley Equity Partners was advised by David Graham & Stubbs LLP (legal advisor).

Media Contact: 

Sheena Smith


About Copley Equity Partners

Copley Equity Partners is a private investment firm with offices in both Boston and Denver. Copley partners with established lower middle-market businesses with significant growth prospects. Copley makes investments into private companies operating across a broad range of sectors. Copley invests out of an evergreen, single-family office capital base and is comfortable in both majority and minority ownership positions. Copley’s patient and flexible capital base allows the firm to maintain a limited portfolio of companies and provide each portfolio company with significant support post-investment. For more information, please visit

About Spend Matters

Spend Matters started as the first blog and social media site in the procurement and supply chain sector and has since grown into the leading source for data-backed technology and solutions intelligence. Serving private and public sector organizations, consultants, private equity, and services and solution providers, Spend Matters drives strategic technology purchasing decisions and superior marketing, product, sales and investment outcomes for clients. Spend Matters is the only tech-enabled, proprietary data platform with exclusive IP that serves the global procurement, finance, and supply chain technology ecosystem.


JEGI CLARITY (, a pre-eminent M&A advisory firm for the global media, marketing, information and technology industries, with a global reach from New York, London, Boston, San Francisco and Sydney, represented Spend Matters in this transaction.

This content was issued through the press release distribution service at

Imperial Capital Opens Authorized European Company in Milan, Italy to Conduct European Business and Names Julien Sida as its CEO

LOS ANGELES, Dec. 09, 2021 (GLOBE NEWSWIRE) — Imperial Capital Group, LLC (“Imperial Capital”) announced that its affiliate, Imperial Capital (International) LLP (“Imperial Capital International”), has completed the process of transitioning its Milan Branch into an authorized subsidiary amidst the end of the Brexit transition period whereby passporting between the UK and EEA states ceased. The new entity is incorporated as Imperial Capital SIM S.p.A. (“Imperial Capital SIM”) and received authorization from the CONSOB and Bank of Italy to operate as an investment firm in Italy, and to passport into other European countries. Imperial Capital’s objective is to make Imperial Capital SIM the driving center for its services in Continental Europe through an expansion of its existing business model. The Milan headquarters is located at Via Torino, 49 – 20123 Milan.

Additionally, Imperial Capital appointed Julien Sida as CEO of Imperial Capital SIM. Mr. Sida, who transfers from Imperial Capital International, joined Imperial Capital in 2015 as a Managing Director in the High Yield Sales Group in London before transferring to Milan. Previously, Mr. Sida was in Credit Sales at KNG Securities, GFI Group & Deutsche Bank. Mr. Sida earned a B.S. from Skema Business School.

“The Milan SIM demonstrates a key evolution of our European franchise, building on the success of our London operation, and leveraging Julien’s significant credit sales experience and relationships. It will help us to better serve our European institutional clients and underscores our commitment to serving the investor community and our long-term commitment to Europe,” said Brian Robertson, Head of Imperial Capital International in Europe.

“Imperial’s ability to adapt is one of our greatest strengths as a company,” said Julien Sida, CEO of Imperial Capital SIM. “Maintaining a comprehensive global sales & trading platform will allow us to expand in Milan as we look to hire key talent whom may be displaced by their current inability to service the continent post Brexit.”

About Imperial Capital SIM S.p.A.

Imperial Capital SIM S.p.A situated in Milan, Italy is an authorized subsidiary of Imperial Capital. Imperial Capital SIM S.p.A operates in the Italian market, and enables us to passport into other EU jurisdictions post Brexit. We are dedicated to maintaining a European presence and developing our international franchise.
Imperial Capital SIM S.p.A is regulated by Commissione Nazionale per le Società e la Borsa (“CONSOB”) and the Bank of Italy.

For more information regarding Imperial SIM S.p.A., please contact:
Julien Sida
+ 44 (0) 207 650 5431

About Imperial Capital (International), LLP

Imperial Capital International, founded in 2011, is an affiliate of Imperial Capital, LLC with an office in central London. Complementing Imperial Capital’s existing corporate credit sales and trading franchise, Imperial Capital International expanded the Imperial Capital franchise into the EEA.  Our UK based professionals focus on the entire credit spectrum and have expertise across sales, trading, credit analysis, and support functions. We provide comprehensive trading in multiple currencies.

For more information regarding Imperial Capital (International), LLP, please contact:
Emma McClintock
+ 44 (0) 207 650 5429

About Imperial Capital, LLC

Imperial Capital, LLC is a full-service investment bank offering a uniquely integrated platform of comprehensive services to institutional investors and middle market companies. We offer sophisticated sales and trading services to institutional investors and a wide range of investment banking advisory, capital markets and restructuring services to middle market corporate clients. Paired with our proprietary research and sales & trading desk analysis, we provide investment analysis across an issuer’s capital structure, including bank loans, debt securities, the hybrid/bank capital marketplace (through our ELP Framework), post-reorganization equities, special situations claims and listed and unlisted equities. Our comprehensive and integrated service platform, expertise across the global capital structure, and deep industry sector knowledge enable us to provide clients with research driven ideas, superior advisory services, and trade execution. We are quick to identify opportunities under any market conditions and we have a proven track record of offering creative, proprietary solutions to our clients. Imperial Capital, LLC has three principal businesses: Investment Banking, Institutional Sales & Trading and Institutional Research. More information about Imperial Capital, LLC can be found at

For more information regarding Imperial Capital, please contact:
Mark Martis
+1 310 246 3674

Unifty: Marrying DeFi and NFTs Through the Gallery



LONDON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Unifty is marrying DeFi and NFTs with the launch of The Gallery, an innovative exhibition space inspired by the platform’s desire to improve upon the traditional gallery-creator relationship. The Gallery’s unique approach to the NFT marketplace means that all participants, including creators, collectors, curators, and fans, are rewarded for engaging on the platform.

The Gallery is both a reimagining of the way creators traditionally showcase their art to the public as well as a reimagining of the NFT platform experience. Through The Gallery, Unifty is ushering decentralized finance (DeFi) into the digital art exhibition and viewing process by rewarding and involving all community participants: from creators, collectors, art lovers, to organizations.

Initially, creators will be able to hold exhibitions in The Gallery for 30 days. Through their NFT exhibitions, they have the opportunity to sell their work, but in a unique twist are guaranteed a yield from simply hosting visitors to their collections.

Collectors, similarly, can hold exhibitions of their NFT collections and earn a yield. Unifty community members who visit the exhibitions also earn from their participation as art lovers. Much like DeFi, the ecosystem rewards participants no matter what their role is on the platform.

The Gallery’s aim is to both rectify the inherent imbalances in the creator-gallery relationship and to elevate the experience of engaging in the NFT landscape through the use of DeFi-type incentives.

How does it work?

Unifty is leveraging its dual-token structure to reward all participants in its ecosystem. $NIF tokens are the platform’s governance token. Holders of $NIF are able to vote on which creators or collectors are chosen to exhibit in The Gallery and vote more generally on the direction of the platform.

Token holders can also stake $NIF to those exhibitions they like. By staking $NIF, community members share earnings in the yield that the exhibition to which they stake generates. That yield is determined by a number of factors, including the agreed market value of the NFTs exhibited, the reputation of the creator, the number of $NIF tokens staked to it, and the number of individual stakers.

Rewards are paid out in Unifty’s reward token, $UNT. The $UNT that is farmed from a particular exhibition in The Gallery is paid out to the exhibitor – whether a collector or a creator – and those fans who staked $NIF to it.

Unifty, in this way, hopes to enhance the world of NFTs through instruments more commonly found in DeFi. Not only do creators get fairly rewarded for their work, through sales and/or through simply exhibiting it, but those who believe in and appreciate their work also earn a yield by staking their loyalty to the work they like, via $NIF tokens.

Unifty’s unique staking and rewarding system promises to enhance the digital art experience by engaging all participants through DeFi incentive and engagement mechanisms.
The Gallery launches on Dec. 9, 2021.
To learn more about Unifty, visit:

Official website:

Gallery website:


Telegram Channel:


Related Images

Image 1: Unifty

This content was issued through the press release distribution service at


Thai Energy Minister to head Jana industrial estate fact-finding panel

Government representatives met with leaders of Jana District protesters today (Friday), to inform them of the appointment by Prime Minister Prayut Chan-o-cha’s of Energy Minister as head the fact-finding committee on the Jana industrial estate project, replacing Deputy Prime Minister Prawit Wongsuwan.

Pansak Charoen, director of the People’s Service Centre under the Prime Minister’s Office and head of the government representatives, also told the protest leaders that Supattanapong’s panel will soon meet with protest leaders to listen to their concerns and would like them to submit their proposals or demands for consideration.

Pansak Charoen, director of the People’s Service Centre under the Prime Minister’s Office and head of the government representatives, also told the protest leaders that Supattanapong’s panel will soon meet with protest leaders to listen to their concerns and would like them to submit their proposals or demands for consideration.

The Jana district protesters have been camping out in front of the UN Building on Ratchadamnoen Nai Road since they were dispersed from the area near Government House on Monday.

Source: Thai Public Broadcasting Service

Cambodian Refugees in Thailand ‘Don’t Feel Safe’ After Arrests, Deportations

BANGKOK — Cambodian political refugees in Thailand say they are living in fear after a spate of arrests and deportations of fellow refugees back to Cambodia by Thai authorities over the past month.

Thailand has arrested five Cambodians registered with the local office of the United Nations High Commissioner for Refugees since early November and forced four of them back to Cambodia, where they were immediately detained on outstanding warrants. The fifth, Bor Bet, was released on bail in Thailand last week and is seeking another country to take him in.

The Center for Asylum Protection, a Thai rights and legal aid group, said that is the fastest pace of deportations of Cambodian refugees from Thailand since the neighbors struck a deal in 2018 to exchange “foreign fugitives” using their countries as a base for “sowing chaos and incitement.”

“Right now we don’t feel safe at all because of the recent events that happened to our colleagues who were arrested by Thai police and then deport[ed] to Cambodia,” Narith, a member of the outlawed Cambodia National Rescue Party who asked that his full name not be used, told VOA by phone from an undisclosed location in Thailand.

The CNRP organizer escaped to Thailand last year while on bail in Cambodia on a charge of conspiring to overthrow the government, which he denies. Narith said he has changed locations three times since the latest arrests started.

Life on the lam

Cambodia’s Supreme Court dissolved the CNRP in 2017 for plotting to topple the government, a move widely seen at home and abroad as politically motivated. The ruling came amid a sweeping government crackdown on unions, rights groups and independent media, and did away with the only viable political challenge to Prime Minister Hun Sen, who has ruled the country for more than 35 years with an increasingly iron grip.

On paper, the court ruling also made criminals of Narith and others still campaigning to oust Hun Sen at the polls under the CNRP banner. Cambodia’s courts have issued dozens of warrants for the arrest of party members.

Narith told VOA that more than 60 CNRP members are still in Thailand since fleeing Cambodia over the past three years.

He said he and others have served time in Cambodia’s overflowing prisons for their politics before and that if forced back, “they would put us in jail again, for sure.”

Fearing arrest by Thai police, Narith said many of them have switched accommodations over the past month, varied their routines and cut back on phone calls and social media posts.

“We have to be careful with the telephone, the internet using, things like that,” he said.

Refugees told VOA they believed they were being watched, followed and photographed in Thailand even before the latest arrests began.

“I changed my place already because I think my old place is not safe,” said another CNRP member hiding in Thailand, speaking on condition of anonymity.

Still, he added, “I feel unsafe every day; we don’t know when the Thai police will arrest anybody and we will [be put] in jail.”

Chhun Sithy, a former commune councilor for the CNRP, also hiding in Thailand, said he has multiple conspiracy convictions waiting for him in Cambodia for continuing to push the CNRP’s cause and would face 10 years in jail if forced back.

He has switched apartments, quit his English language classes to keep indoors and suspended broadcasts of his online talk show about Cambodia.

“I [am] afraid that if they can send my fellows to Cambodia they will send me also,” he said.

Refugee rights

Narith said most Cambodian refugees in Thailand crossed over illegally to avoid capture at official border checkpoints. Since arriving, though, he added that nearly all of them have registered with the UNHCR and had their refugee claims recognized.

The Center for Asylum Protections says that recognition should spare them a forced return to Cambodia, where, it adds, they have little chance of a fair trial.

“They [were] all recognized as a refugee, so, for refugees at least, Thailand has to protect them from deportation,” said Rawitsara Piakhuntod, a protection officer for the center.

Although Thailand has not signed the U.N.’s Refugee Convention, the UNHCR says the country is still bound to international law of nonrefoulment, which bars governments from sending people back to countries likely to persecute them, by the other treaties it has joined.

“UNHCR has expressed its concerns and urged the Royal Thai Government to refrain from deporting recognized refugees and to abide by its international obligations, particularly the principle of non-refoulement,” Catherine Stubberfield, a spokesperson for the U.N. agency’s regional bureau for Asia and the Pacific, told VOA.

In a statement last month, Human Rights Watch said Thailand’s forced return of refugees showed a “blatant disregard” for those principles.

Thai Foreign Affairs Ministry spokesperson Tanee Sangrat would not answer questions about the recent arrests and deportations.

Spokespeople for the central government and national police did not answer multiple calls and repeated messages requesting comment.

Achayon Kraithong, a spokesperson for Thailand’s immigration bureau, told Reuters last month that the government would prioritize the country’s immigration laws but avoid sending people into danger.

Source: Voice of America

Super-duo Dechapol and Sapsiree smash Thai badminton back to top of the world

Thailand underlined its status as a global badminton power on Tuesday (Dec 7), when Dechapol Puavaranukroh and Sapsiree Taerattanachai claimed the mixed doubles No 1 throne in the latest rankings released by the Badminton World Federation (BWF).

First for Thailand

Following their victory at the BWF World Tour Finals in Bali on Sunday (Dec 5), the doubles specialists climbed up a notch to the pinnacle, taking over the top position from arch-rivals Zheng Si Wei and Huang Ya Qiong of China. In doing so, they became the first Thai pair in history to be ranked world No 1 in mixed doubles.

“This is not beyond our goal,” said 29-year-old Sapsiree, from Udon Thani. “In every tournament we enter, we expect to either reach the final or win the title. Achieving that in several tournaments meant we reached the No 1 spot. However, we feel honored to have created fame for the country,” said Sapsiree. She and Dechapol also became the second and third Thais to reach No 1 in world badminton after Ratchanok Intanon topped the women’s singles rankings back in April 2016.

So far this year, the super duo has competed in 11 events and finished top of the podium in 7 tournaments – Thailand Open I and II, 2020 BWF World Tour Finals in Thailand (in January), the Hylo Open in Germany, Indonesian Masters, Indonesian Open and 2021 World Tour Finals in Bali – winning the latter four consecutively. They have won 45 out of 51 matches played this season and are on a 20-match winning streak after taking the first spot in their last four tournaments.

“It’s tough to win a title, but defending a title is tougher. Today, we made it,” the 24-year-old Dechapol posted on Instagram after the duo retained their title at the World Tour Finals with a 21-19 21-11 victory over Yuta Watanabe and Arisa Higashino of Japan.

Journey to global domination

Dechapol and Sapsiree teamed up for the first time in 2015 but it took them two years to clinch their first gold medal together, at the 2017 Swiss Open. It wasn’t until 2019 that they began to signal their status as a mixed doubles force to be reckoned with. That year they claimed a hat-trick of titles – the Singapore Open, Korea Open and Macau Open.

Olympic goal next

But despite climbing to the summit of the world rankings, there are a few challenges Dechapol and Sapsiree have yet to conquer. Gold medals in the Asian Games, World Championships and Olympics gold medals have yet to be added to their portfolio. And time may be running out. Sapsiree will be 32 by the time she takes aim at her Olympic dream in the 2024 Paris Games.

“I believe I will stay physically fit over the next three years for the Olympics. One of our remaining goals is to grab an Olympic gold,” said Sapsiree, who holds the record as the only player to win tournaments in three BWF categories: mixed doubles, women’s doubles (with Puttita Supajirakul in the 2016 Thailand Open/2019 Thailand Masters; and with Savitree Amitrapai 2012 India Grand Prix Gold) and the women’s singles in the 2013 US Open.

The No 1 mixed doubles duo will wrap up their year in the World Championships, which starts on December 12 in Huelva, Spain. After the Indonesia swing, the year-end tournament will serve as a stiffer test for the pairing as it marks the return of their arch-rivals Zheng and Huang, two-time world champions who hold a superior career-match record of 8-2 over the Thais. The Chinese duo has barely played this year due to COVID concerns. If both pairs live up to their seeding, they are due to meet in a mouth-watering final.

“There’s no pressure on us [going to the World Championships]. Right now, I don’t want to think too far ahead. We need to recover [from playing three straight weeks in Indonesia] first,” said Dechapol, who hails from Chonburi province.

The duo from Thailand last took on their Chinese opponents two years ago in the Korea Open, in a match won by the Thais. Another victory over their old foes will serve as a morale booster, clearing all doubts about whether they deserve the No 1 spot with the recent absence of Zheng and Huang from the circuit.

“I hope to at least reach the final, but to win will be better. With the way we are playing now, I’m confident we can match any team in the world. It will all come down to how well we can perform on the day. We really have to come up with a good game plan,” said Sapsiree, whom Indonesian fans took to their hearts this month, showering her hotel room in Bali with gifts and bouquets.

Thai badminton rising

Hopes are rising again for Thai badminton, with Dechapol and Sapsiree’s achievements coinciding with Kunlavut Vitidsarn being named BWF Most Promising Player of the Year in men’s singles, and world No 10 Pornpavee Chochuwong hitting hot form in women’s singles. Stay tuned for more Thai glory on the courts next year.

Source: Thai Public Broadcasting Service